Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients (Q34699979)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients |
scientific article |
Statements
1 reference
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients (English)
1 reference
Gen Sobue
1 reference
Koji Abe
1 reference
Yasuto Itoyama
1 reference
Shoji Tsuji
1 reference
Masashi Aoki
1 reference
Manabu Doyu
1 reference
Chikuma Hamada
1 reference
Kazuoki Kondo
1 reference
Takatomo Yoneoka
1 reference
Makoto Akimoto
1 reference
Hiide Yoshino
1 reference
Edaravone ALS Study Group
1 reference
6 October 2014
1 reference
15
1 reference
7-8
1 reference
610-617
1 reference
6 October 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference